These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6283752)

  • 1. [Human papillomavirus and oncogenesis (author's transl)].
    Jabłońska S
    Z Hautkr; 1982 Apr; 57(8):551-66. PubMed ID: 6283752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological studies in epidermodysplasia verruciformis.
    Jablonska S; Orth G; Jarzabek-Chorzelska M; Rzesa G; Obalek S; Glinski W; Favre M; Croissant O
    Bull Cancer; 1978; 65(2):183-90. PubMed ID: 212145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New developments relating to papillomaviruses].
    Jablonska S; Orth G; Jarzabek-Chorzelska M; Obalek S; Rzesa G; Croissant O; Favre M
    Hautarzt; 1979 Aug; 30(8):411-7. PubMed ID: 229087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic potential of human papillomaviruses epidermodysplasia verruciformis: a counterpart of Shope papilloma-carcinoma complex.
    Jabłonska S; Orth G; Obalek S; Croissant O; Jarzabek-Chorzelska M; Favre M; Kremsdorf D
    Arch Geschwulstforsch; 1983; 53(3):207-15. PubMed ID: 6311135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology and pathological associations of the human papillomaviruses: a review.
    Cheah PL; Looi LM
    Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue effects of and host response to human papillomavirus infection.
    Jenson AB; Kurman RJ; Lancaster WD
    Dermatol Clin; 1991 Apr; 9(2):203-9. PubMed ID: 1647900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human papillomavirus-associated disease with disseminated warts, depressed cell-mediated immunity, primary lymphedema, and anogenital dysplasia: WILD syndrome.
    Kreuter A; Hochdorfer B; Brockmeyer NH; Altmeyer P; Pfister H; Wieland U;
    Arch Dermatol; 2008 Mar; 144(3):366-72. PubMed ID: 18347293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidermodysplasia verruciformis (2 cases). Immunological study (author's transl)].
    Guilhou JJ; Malbos S; Barnéon S; Habib A; Baldet P; Meynadier J
    Ann Dermatol Venereol; 1980 Jul; 107(7):611-9. PubMed ID: 6254427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphologic manifestations of human papillomavirus infection in the vulvar and anogenital region].
    Hadzić B; Djurdjević S; Hadzić M; Jerant-Patić V
    Med Pregl; 1998; 51(5-6):265-70. PubMed ID: 9720356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Warts, viruses, cancer (author's transl)].
    Pruniéras M
    Ann Dermatol Venereol; 1978 May; 105(5):479-83. PubMed ID: 213005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin autografts in epidermodysplasia verruciformis: human papillomavirus-associated cutaneous changes need over 20 years for malignant conversion.
    Majewski S; Jablonska S
    Cancer Res; 1997 Oct; 57(19):4214-6. PubMed ID: 9331078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunity of the female genital tract mucosa and mechanisms of papillomavirus evasion].
    Riethmuller D; Seilles E
    J Gynecol Obstet Biol Reprod (Paris); 2000 Dec; 29(8):729-740. PubMed ID: 11139708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue effects of and host response to human papillomavirus infection.
    Jenson AB; Kurman RJ; Lancaster WD
    Obstet Gynecol Clin North Am; 1987 Jun; 14(2):397-406. PubMed ID: 2829077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus: disease and laboratory diagnosis.
    Swygart C
    Br J Biomed Sci; 1997 Dec; 54(4):299-303. PubMed ID: 9624741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local immunological reactivity in oral squamous cell lesions of possible HPV (human papillomavirus) origin.
    Syrjänen KJ; Syrjänen SM; Lamberg MA; Happonen RP
    Arch Geschwulstforsch; 1983; 53(6):537-46. PubMed ID: 6322720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroreactivity to epidermodysplasia verruciformis-related human papillomavirus types is associated with nonmelanoma skin cancer.
    Feltkamp MC; Broer R; di Summa FM; Struijk L; van der Meijden E; Verlaan BP; Westendorp RG; ter Schegget J; Spaan WJ; Bouwes Bavinck JN
    Cancer Res; 2003 May; 63(10):2695-700. PubMed ID: 12750299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermodysplasia verruciformis versus disseminated verrucae planae: is epidermodysplasia verruciformis a generalized infection with wart virus?
    Jablonska S; Orth G; Jarzabek-Chorzelska M; Rzesa G; Obałek S; Glinski W; Favre M; Croissant O
    J Invest Dermatol; 1979 Mar; 72(3):114-9. PubMed ID: 217936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for cervical neoplasia in Denmark.
    Kjaer SK
    APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylactic and therapeutic vaccination against human papillomavirus].
    Brun JL; Riethmuller D
    J Gynecol Obstet Biol Reprod (Paris); 2007 Nov; 36(7):631-41. PubMed ID: 17822860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
    Syrjänen KJ
    Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.